CanSinoBIO's COVID-19 vaccine 74.8% effective in Pakistan trials

CGTN

text

China's CanSino Biologics Inc.'s (CanSinoBIO) COVID-19 vaccine showed 74.8 percent efficacy in preventing symptomatic cases and a 100-percent success rate in stopping severe disease among Pakistanis in Phase III clinical trials, Special Assistant to the Prime Minister on Health Dr. Faisal Sultan said on Monday.